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Abstract
Background: Leiomyosarcoma of vascular smooth muscle is a very rare entity. A fair number of cases of vascular
leiomyosarcomas have been reported, and the vast majority of these tumors arose from the inferior vena cava.
Case Presentation: We report the case of a 71-year-old female patient who presented with recurrent upper
abdominal pain.
A CT-scan demonstrated a heterogenous mass in the liver hilum. Liver function tests and hematology parameters
as well as the tumor markers were normal. Due to the unclear diagnosis a percutaneous biopsy of this mass was
performed and revealed leiomyosarcoma. The patient was treated by a right sided hemihepatectomy with portal
vein reconstruction and an end-to-side hepatico-jejunostomy. Final histology confirmed complete (R0) resection
of a moderately differentiated leiomyosarcoma of the portal vein. After complete (R0) resection of the lesion, the
patient remained without any signs of tumor recurrence for a total of 36 months until detection of an unresectable
local recurrence. After surgical re-exploration the patient was finally referred to palliative radiotherapy.
Conclusion: Vascular leiomyosarcoma of the portal vein is an extremely rare tumor entity. We have described a case
with no evidence-based neo/adjuvant treatment options, where aggressive surgery achieved a tumor-free margin (R0),
performed in a specialized center for sarcoma and hepatobiliary surgery.
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Background
Leiomyosarcoma is a malignant mesenchymal tumor
of smooth muscle cells representing the second most
frequent malignant soft tissue tumor in adults after
liposarcoma. Perl initially described vascular leiomyo-
sarcoma in 1871, which is a rare disease: so far, only
a few hundred patients with vascular leiomyosarcoma
have been reported in the literature. Vascular leio-
myosarcoma most often arise from the inferior vena
cava (IVC). Less frequently they have been described
in the renal, mesenteric, hepatic and saphenous veins,
or even in arteries [1–5]. Only one leiomyosarcoma
of the portal vein has been described in the English
or German literature so far [6].
Case Presentation
We report the case of a 71-year-old female patient who
presented with recurrent upper abdominal pain. CT-
scan demonstrated a heterogenous mass in the liver
hilum, which infiltrated the main portal vein up to the
right branch. The common hepatic artery was displaced
to the left but not encased by the tumor. No signs of
biliary obstruction were seen (Fig. 1).
Liver function tests and hematology parameters as well
as the tumor markers α-fetoprotein, CA 19–9, CEA, and
chromogranin A were normal. Due to the unclear diagno-
sis, a percutaneous biopsy was performed which revealed
leiomyosarcoma. Since no distant metastases were evident
upon staging CT, the patient was referred to our centre
for surgical treatment.
In February 2012, surgical exploration was performed,
which confirmed the extension of the tumor from the
main portal vein into the right portal branch. In contrast
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to the preoperative staging, the tumor infiltrated both
the right hepatic artery and the bile duct. The left
branches of the hepatic artery, portal vein and bile duct
were not affected by the tumor (Fig. 2a).
Due to the extent of the tumor, a right hepatectomy
was performed with an en-bloc resection of the hilar bile
duct bifurcation and lymphadenectomy. Reconstruction
of the portal vein was achieved by an end-to-end-anasto-
mosis, and an end-to-side hepatico-jejunostomy was
performed for biliary reconstruction (Fig. 2b).
Postoperatively, the liver function was normal, and
serial duplex ultrasound examinations and CT-scans
confirmed regular flow in the portal vein. A bile leak
from the hepatico-jejunostomy caused an abscess in
the liver hilum and required an additional percutan-
eous drainage and antibiotic therapy. The patient was
discharged from hospital 6 weeks postoperatively in good
general condition.
Based on the microscopic morphology and immunhis-
tochemic detection of strong expression of Actin and
Caldesmon within the tumor cells the diagnosis of a
moderately differentiated leiomyosarcoma (G2) with up
to 15 mitoses in 10 high power fields was made. Nec-
rotic areas were only found in about 5 % of the tumor
volume (FNCLCC-score: 5/8). For the definition of re-
section status, the specimen was microscopically evalu-
ated for the resection status by sampling of the distal
and proximal resection margins of the portal vein, bile
duct, right hepatic artery as well as the parenchymal
resection margin of the liver. Complete resection (R0)
was confirmed (Fig. 3).
The patient did not receive adjuvant treatment. A follow-
up CT-scan 36 months postoperatively revealed tumor re-
currence in the liver hilum (Fig. 4). Due an excellent gen-
eral condition, the patient underwent re-exploration, which
unfortunately revealed an unresectable local recurrence in
Fig. 1 The preoperative contrast enhanced computed tomography scan demonstrated a heterogenous mass in the liver hilum which infiltrated
the right portal vein. The hepatic artery was displaced by the tumor. However, CT did not reveal infiltration of the hepatic artery
Fig. 2 Intraoperative situs prior to resection (a): the portal vein was involved by the tumor from the upper margin of the pancreas up to the liver
on the right side. The left portal vein was marked with blue rubber bands – both, the left branch (*) and supra-pancreatic part (**) were tumor-free.
The right portal vein is marked by the forceps. The bile duct has been resected. The right hepatic artery has been ligated and the common hepatic
artery has been fully mobilized to the left (red rubber band). In the resected specimen (b), the tumor has been split and the orifice of the right
portal vein is intubated
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the portal vein. The patient recovered quickly from this re-
operation and received palliative radiotherapy with 50.4Gy
until June 2015. The first follow-up MR imaging demon-
strated a partial response of the tumor.
Discussion
Vacular leiomyosarcoma is a rare tumor entity, which
predominantly occurs in the IVC: more than 250
patients have been entered into a patient registry for this
disease [4, 7]. An analysis of this registry indicated surgi-
cal resection of the tumor with negative margins as the
most important prognostic factor, which achieves a 5-
year survival of 33–68 % [8]. In contrast, only one case
of leiomyosarcoma from the portal vein has been re-
ported in the literature, yet. This tumor was however
unresectable, and no long-term follow-up was reported
Fig. 3 a Hematoxylin-eosin (HE) staining of the surgical specimen (magnification × 40). Arrows surrounding the portal vein, bundles of neoplastic
smooth muscle cells partially infiltrating the portal vein (*). b HE staining of the surgical specimen (magnification × 100). Arrows indicate the
adventitia of the hepatic artery without infiltration of the arterial wall (+). c, d The tumor stained positive for smooth muscle actin (c) and
caldesmon (d) upon immunohistochemistry (magnification × 100)
Fig. 4 The CT scan 36 months after curative resection reveals intrahepatic tumor recurrence (arrows) arising from the left portal vein. The heterogenous
texture of the liver on the right side of the tumor is caused by heterogenous perfusion of this hepatic area and is constant since primary surgery
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from this case [6]. More recently, Frazzoni and colleagues
described a leiomyosarcoma in a 44-year old female near
the portal vein without infiltration of the vascular wall.
Tumor recurrence was found 27 month after curative re-
section, and the patient died 47 months after surgery [9].
Similarly, our patient developed local recurrence after
36 months. Due to the limited follow-up after radiother-
apy, the long-term survival is unknown.
In addition to the rare incidence, the variable histological
appearance may complicate the diagnosis of vascular leio-
myosarcoma. Due to the etiology of leiomyosarcoma, it
usually shares characteristics of benign leiomyoma such as
bundles of smooth muscle cells with central cigar-shaped
nucleus, but cells also have eosinophilic cytoplasm and
often perinuclear vacuoles. Usually, leiomyosarcoma stains
positive for vimentin and smooth muscle actin, and they
typically express desmin. Commonly, these tumors are
negative for protein S-100 and neuron-specific enolase.
However, expression of protein S-100, Leu 7, and epithelial
membrane antigen have also been reported for leiomyosar-
coma [2]. Morphology and immunohistochemical staining
of the present case are in line with these features and thus
confirm the diagnosis of leiomyosarcoma (Fig. 3).
Also due to the low incidence of this tumor, no adju-
vant or neoadjuvant chemotherapy or radiotherapy regi-
men has been established for vascular leiomyosarcoma
[2, 4, 7]. Up to date, radical resection aiming at complete
local tumor clearance remains the primary treatment mo-
dality for patients with resectable vascular leiomyosarcoma
and may achieve a favourable outcome [2–4, 7, 8, 10].
Considering the local recurrence in our patient, an ad-
juvant radiation therapy should have been considered.
However, an adjuvant treatment is not recommended
in the literature. Furthermore, the patient was dis-
charged from hospital six weeks after surgery following
a complicated course with an infectious complication.
Therefore, the patient did not receive adjuvant therapy
based on an interdisciplinary board discussion. More-
over, a de-novo sarcoma of a portal venous branch
three years after the initial resection should also be
taken into consideration, since the development of a
real local recurrence with such delay after an appar-
ently R0-resection appears unusal. Also, down-sizing
therapies for unresectable tumors have failed to im-
prove prognosis in a limited number of patients [8].
Conclusions
Vascular leiomyosarcoma of the portal vein is an ex-
tremely rare tumor entity. In the absence of established
neo/adjuvant treatment options, aggressive surgery seems
to be the most reasonable treatment if tumor-free margins
(R0) can be achieved. Based on the complexity of the
hilar anatomy and the prognosis of unresectable dis-
ease, the treatment of this tumor entity should only
be performed in specialized centres for sarcoma and
hepato-biliary surgery.
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